News
4d
MedPage Today on MSNNew FDA Drug Chief: 'Revolving Door' or Reformer?Did George Tidmarsh, MD, PhD, enter the FDA through the very revolving door its new leadership pledged to close? The founder ...
The Food and Drug Administration has approved a vagus nerve bioimplant to treat rheumatoid arthritis (RA). The scientific ...
“Dr. Tidmarsh is an accomplished physician-scientist and leader whose experience spans the full arc of drug development — ...
Novo Nordisk tapped Maziar Mike Doustdar, its head of international operations, as its new chief executive officer and ...
Stanford's George Tidmarsh has authored 143 scientific papers and patents, as well as played a central role in developing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results